Penile involvement with hand-foot syndrome

American Journal of Clinical Dermatology

Volumn 5, Issue 3, 2004, Pages 209-210

  Sorscher, Steven M ^a  

^a MARSHFIELD CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRYOSTATIN; CISPLATIN; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; PACLITAXEL; PYRIDOXINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CASE REPORT; ESOPHAGOGASTROSTOMY; GASTROINTESTINAL CARCINOMA; HAND FOOT SYNDROME; HUMAN; MALE; PENIS; PRIORITY JOURNAL; TUMOR BIOPSY;

ANTINEOPLASTIC AGENTS; DRUG ERUPTIONS; FLUOROURACIL; FOOT DERMATOSES; HAND DERMATOSES; HUMANS; MALE; MIDDLE AGED; PENILE DISEASES;

EID: 3142630201     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200405030-00010     Document Type: Article

References (14)

1. Nagore E, Insa A, Sanmartin O. Antineoplastic therapy-induced palmar plantar erythrodysesthesia ('hand-foot') syndrome: incidence, recognition and management. Am J Clin Dermatol 2000 Jul-Aug; 1 (4): 225-34
2. Baer MR, King LE, Wolff SN. Palmar-plantar erythrodysesthesia and cytarabine [letter]. Ann Intern Med 1985 Apr; 102 (4): 556
3. Herzig RH, Wolff SN, Lazarus HM, et al. High-dose cytosine arabinoside therapy for refractory leukemia. Blood 1983; 62: 361-9
4. Hines JD, Zakem MH, Adelstein TJ, et al. Treatment of advanced stage colorectal adenocarcinoma with fluorouracil and high-dose leucovorin calcium: a pilot study. J Clin Oncol 1988; 6: 142-6
5. Hoff PM, Valero V, Ibrahim N, et al. Hand-foot syndrome following prolonged infusion of high doses of vinorelbine. Cancer 1998 Mar 1; 82 (5): 956-9
6. Ikeda H, Kawano H, Kitaura T, et al. Acral erythema associated with high-dose methotrexate infusion [case report]. Ann Pharmacother 1999 May; 33 (5): 646
7. Jucgla A, Sais G, Navarro M, et al. Palmoplantar keratoderma secondary to chronic acral erythema due to tegafur. Arch Dermatol 1995 Mar; 131 (3): 364-5
8. Kampmann KK, Graves T, Rogers SD. Acral erythema secondary to high-dose cytosine arabinoside with pain worsened by cyclosporine infusions. Cancer 1989 Jun 15; 63 (12): 2482-5
9. Koletsky A, Jahanzeb M, Radice P, et al. A randomized phase II trial of pegylated liposomal doxorubicin (PG-LD) as second line treatment in non-small cell lung cancer (NSCLC) patients with prior exposure to platinum based therapy [abstract 1888]. Proc Am Soc Clin Oncol 1998; 17: 490A
10. Kroll SS, Koller CA, Kaled S, et al. Chemotherapy-induced acral erythema: desquamating lesions involving the hands and feet. Ann Plast Surg 1989 Sep; 23 (3): 263-5
11. Lokich JJ, Ahlgren JD, Gullo JJ, et al. A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program study. J Clin Oncol 1989; 7: 425-32
12. Susser WS, Whitaker-Worth DL, Grant-Kels JM. Mucocutaneous reactions to chemotherapy. J Am Acad Dermatol 1999; 40: 367-98
13. Baack BR, Burgdorf WH. Chemotherapy-induced acral erythema. J Am Acad Dermatol 1991; 24 (3): 457-61
14. Chiara S, Nobile MT, Barzacchi C, et al. Hand-foot syndrome induced by high-dose, short-term, continuous 5-fluorouracil infusion. Eur J Cancer 1997; 33 (6): 967-9